Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1615626
Max Phase: Preclinical
Molecular Formula: C15H15N2O12PS2
Molecular Weight: 510.40
Molecule Type: Small molecule
Associated Items:
ID: ALA1615626
Max Phase: Preclinical
Molecular Formula: C15H15N2O12PS2
Molecular Weight: 510.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc(/N=N/c2ccc(S(=O)(=O)O)cc2S(=O)(=O)O)c(COP(=O)(O)O)c(C=O)c1O
Standard InChI: InChI=1S/C15H15N2O12PS2/c1-8-4-13(11(7-29-30(20,21)22)10(6-18)15(8)19)17-16-12-3-2-9(31(23,24)25)5-14(12)32(26,27)28/h2-6,19H,7H2,1H3,(H2,20,21,22)(H,23,24,25)(H,26,27,28)/b17-16+
Standard InChI Key: FFLAALLXNFGXRL-WUKNDPDISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 510.40 | Molecular Weight (Monoisotopic): 509.9804 | AlogP: 2.03 | #Rotatable Bonds: 8 |
Polar Surface Area: 237.52 | Molecular Species: ACID | HBA: 10 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 14 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: -3.31 | CX Basic pKa: | CX LogP: -1.92 | CX LogD: -5.98 |
Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.15 | Np Likeness Score: 0.02 |
1. Pislyagin E,Kozlovskiy S,Menchinskaya E,Chingizova E,Likhatskaya G,Gorpenchenko T,Sabutski Y,Polonik S,Aminin D. (2021) Synthetic 1,4-Naphthoquinones inhibit P2X7 receptors in murine neuroblastoma cells., 31 [PMID:33401207] [10.1016/j.bmc.2020.115975] |
2. Mahmood A, Ali Shah SJ, Iqbal J.. (2022) Design and synthesis of adamantane-1-carbonyl thiourea derivatives as potent and selective inhibitors of h-P2X4 and h-P2X7 receptors: An Emerging therapeutic tool for treatment of inflammation and neurological disorders., 231 [PMID:35123298] [10.1016/j.ejmech.2022.114162] |
Source(1):